Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
02 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizals-zegfrovy-sunvozertinib-receives-fda-accelerated-approval-as-the-only-targeted-oral-treatment-for-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-302497351.html
19 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-completes-enrollment-for-its-phase-iii-pivotal-study-of-sunvozertinib-vs-platinum-doublet-in-treatment-naive-nsclc-patients-with-egfr-exon20-insertional-mutations-302486187.html
12 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-showcases-two-first-in-class-therapies-in-hematologic-malignancies-at-eha-and-icml-2025-302480124.html
26 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-to-highlight-its-portfolio-advances-in-hematologic-malignancies-and-lung-cancer-at-asco-2025-302465161.html
15 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-to-present-promising-clinical-data-on-golidocitinib-and-dzd8586-for-the-treatment-of-lymphoma-at-the-coming-international-hematology-conferences-302456499.html
24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-to-showcase-data-in-hematologic-malignancies-and-lung-cancer-at-asco-2025-302437224.html
ABOUT THIS PAGE